Alcresta Therapeutics
AcquiredEnzyme products designed for enteral nutrition
United States · $69.0M raised
- Business Model
- B2B
- Website
- alcresta.com
- Total Funding
- $69.0M
- Last Round
- $49.0M Series CJun 2016
- Rounds
- 3
About
Alcresta Therapeutics delivers novel enzyme-based products improving nutritional care for enterally fed patients with rare diseases.
Summary
Alcresta Therapeutics is a Biotech company based in United States. It has raised $69.0M in total across 3 rounds, most recently a $49.0M Series C round in Jun 2016. Investors include Linden Capital Partners and Bessemer VP.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...